GRIA2 and amyotrophic lateral sclerosis: While there appear to be differences in the AMPA receptor subunits expressed in ALS patients, the common denominator is a reduced GluA2/GluA1 ratio that leads to enhanced Ca2+ permeability of the receptors (Figure 3).